Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Heaney, Liam G"'
Autor:
Stone JH; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States. Electronic address: jhstone@mgh.harvard.edu., McDowell PJ; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Jayne DRW; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Merkel PA; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Robson J; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Patel NJ; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Zhang Y; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Yue H; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Bekker P; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States., Heaney LG; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
Publikováno v:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2022 Aug; Vol. 55, pp. 152010. Date of Electronic Publication: 2022 Apr 15.
Autor:
McDowell PJ; Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, UK., Stone JH; Division of Rheumatology, Allergy, and Clinical Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Zhang Y; Division of Rheumatology, Allergy, and Clinical Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Honeyford K; Dept of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK., Dunn L; Dept of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK., Logan RJ; Dept of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK., McGarvey LPA; Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, UK., Butler CA; Dept of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK., Heaney LG; Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, UK l.heaney@qub.ac.uk.
Publikováno v:
The European respiratory journal [Eur Respir J] 2022 Jan 20; Vol. 59 (1). Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).
Autor:
McDowell PJ; Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, United Kingdom., Stone JH; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., Zhang Y; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., Honeyford K; Department of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., Dunn L; Department of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., Logan RJ; Department of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., Butler CA; Department of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom., McGarvey LPA; Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, United Kingdom., Heaney LG; Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, United Kingdom. Electronic address: l.heaney@qub.ac.uk.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Jan; Vol. 9 (1), pp. 365-372.e5. Date of Electronic Publication: 2020 Sep 01.
Autor:
Wang E; Division of Allergy & Clinical Immunology, Department of Medicine, National Jewish Health, Denver, CO, and Division of Allergy & Clinical Immunology, Department of Internal Medicine, University of Colorado Hospital, Aurora, CO., Wechsler ME; NJH Cohen Family Asthma Institute, Department of Medicine, National Jewish Health, Denver, CO., Tran TN; AstraZeneca, Gaithersburg, MD., Heaney LG; UK Severe Asthma Network and National Registry, Queen's University Belfast, Belfast, Northern Ireland., Jones RC; Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, United Kingdom., Menzies-Gow AN; UK Severe Asthma Network and National Registry, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom., Busby J; UK Severe Asthma Network and National Registry, Queen's University Belfast, Belfast, Northern Ireland., Jackson DJ; UK Severe Asthma Network and National Registry, Guy's and St Thomas' NHS Trust and Division of Asthma, Allergy & Lung Biology, King's College London, London, United Kingdom., Pfeffer PE; UK Severe Asthma Network, Barts Health NHS Trust and Queen Mary University of London, London, United Kingdom., Rhee CK; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Cho YS; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Canonica GW; Personalized Medicine Asthma & Allergy Clinic, Humanitas University & Research Hospital, Milan, Italy and SANI-Severe Asthma Network Italy, Italy., Heffler E; Personalized Medicine Asthma & Allergy Clinic, Humanitas University & Research Hospital, Milan, Italy and SANI-Severe Asthma Network Italy, Italy., Gibson PG; Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia., Hew M; Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, VIC, Australia; Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Peters M; Department of Thoracic Medicine, Concord Hospital, Sydney, NSW, Australia., Harvey ES; Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia., Alacqua M; AstraZeneca plc, Cambridge, United Kingdom., Zangrilli J; AstraZeneca, Gaithersburg, MD., Bulathsinhala L; Optimum Patient Care Global Ltd, Cambridge, England., Carter VA; Optimum Patient Care Global Ltd, Cambridge, England., Chaudhry I; Optimum Patient Care Global Ltd, Cambridge, England., Eleangovan N; Optimum Patient Care Global Ltd, Cambridge, England., Hosseini N; Optimum Patient Care Global Ltd, Cambridge, England., Murray RB; Optimum Patient Care Global Ltd, Cambridge, England., Price DB; Optimum Patient Care Global Ltd, Cambridge, England; Observational and Pragmatic Research Institute, Singapore, Republic of Singapore; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: dprice@opri.sg.
Publikováno v:
Chest [Chest] 2020 Apr; Vol. 157 (4), pp. 790-804. Date of Electronic Publication: 2019 Nov 27.
Autor:
Miloslavsky EM; Rheumatology, Allergy and Immunology Division, Massachusetts General Hospital, Boston, Massachusetts, USA., Naden RP; Maternal-Fetal Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada., Bijlsma JW; Department of Rheumatology, UMCUtrecht, Utrecht, Netherlands., Brogan PA; Institute of Child Health, University College London, UCL Inst of Child Health, London, UK., Brown ES; Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA., Brunetta P; Late Stage Immunology Product Development, Genentech, Inc., South San Francisco, USA., Buttgereit F; Department of Rheumatology and Immunology, Charité University Medicine Berlin, Berlin, Germany., Choi HK; Department of Rheumatology, Harvard Medical School, Boston, Massachusetts, USA., DiCaire JF; Pinnacle, Inc., Montreal, Quebec, Canada., Gelfand JM; University of California-San Francisco, San Francisco, USA., Heaney LG; Queen's University of Belfast, Belfast, UK., Lightstone L; Section of Renal Medicine and Vascular Inflammation, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, Imperial College London, London, UK., Lu N; Department of Rheumatology, Massachusetts General Hospital, Boston, USA., Murrell DF; University of New South Wales, Sydney, New South Wales, Australia., Petri M; Department of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA., Rosenbaum JT; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA., Saag KS; UAB Division of Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Urowitz MB; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Canada., Winthrop KL; Oregon Health Sciences University, Portland, Oregon, USA., Stone JH; Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Rheumatology Clinic, Boston, Massachusetts, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2017 Mar; Vol. 76 (3), pp. 543-546. Date of Electronic Publication: 2016 Jul 29.
Autor:
Sweeney J; Centre for Infection and Immunity, Queen's University of Belfast, Belfast, UK., Patterson CC; Centre for Public Health, Queen's University of Belfast, Belfast, UK., Menzies-Gow A; Royal Brompton Hospital, London, UK., Niven RM; MAHSC, The University of Manchester & UHSM, Manchester, UK., Mansur AH; Severe and Brittle Asthma Unit, Birmingham Heartlands Hospital, Birmingham, UK., Bucknall C; Department of Respiratory Medicine, Royal Infirmary, Glasgow, UK., Chaudhuri R; Division of Immunology, Infection and Inflammation, Department of Respiratory Medicine, University of Glasgow and Gartnavel General, Glasgow, UK., Price D; Academic Primary Care, University of Aberdeen, Aberdeen, UK., Brightling CE; Department of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, UK., Heaney LG; Centre for Infection and Immunity, Queen's University of Belfast, Belfast, UK.
Publikováno v:
Thorax [Thorax] 2016 Apr; Vol. 71 (4), pp. 339-46. Date of Electronic Publication: 2016 Jan 27.
Autor:
McNicholl DM; Centre for Infection and Immunity, Queen's University of Belfast, Belfast, BT12 6BN, Northern Ireland, UK., Heaney LG
Publikováno v:
Current drug safety [Curr Drug Saf] 2010 Apr; Vol. 5 (2), pp. 182-7.
Autor:
Sweeney, Joan, Brightling, Chris E, Menzies-Gow, Andrew, Niven, Robert, Patterson, Chris C, Heaney, Liam G
Publikováno v:
Sweeney, J, Brightling, C E, Menzies-Gow, A, Niven, R, Patterson, C C & Heaney, L G 2012, ' Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry ', Thorax, vol. 67, no. 8, pp. 754-756 . https://doi.org/10.1136/thoraxjnl-2012-201869
Thorax
Thorax
Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Networ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::aae45c67e106bdaab0e4a481233c4067
https://pure.qub.ac.uk/en/publications/clinical-management-and-outcome-of-refractory-asthma-in-the-uk-from-the-british-thoracic-society-difficult-asthma-registry(c4f0c98a-5cd0-41ff-b18e-94882f79253b).html
https://pure.qub.ac.uk/en/publications/clinical-management-and-outcome-of-refractory-asthma-in-the-uk-from-the-british-thoracic-society-difficult-asthma-registry(c4f0c98a-5cd0-41ff-b18e-94882f79253b).html